NAVLE Integumentary

Equine Aural Plaques Study Guide

Aural plaques (also known as papillary acanthoma, pinnal acanthosis, or hyperplastic aural dermatitis) are a common, benign papillomavirus-induced skin condition affecting the inner surface of the equine pinna.

Overview and Clinical Importance

Aural plaques (also known as papillary acanthoma, pinnal acanthosis, or hyperplastic aural dermatitis) are a common, benign papillomavirus-induced skin condition affecting the inner surface of the equine pinna. These lesions are characterized by well-demarcated, depigmented, hyperkeratotic plaques that rarely spontaneously resolve. While typically asymptomatic and primarily a cosmetic concern, aural plaques can cause significant ear sensitivity and behavioral issues in affected horses, making this a frequently tested topic on the NAVLE.

The clinical prevalence of aural plaques in horses is significant, with studies demonstrating that at least 22% of horses are affected, and some regional studies in Brazil have found prevalence rates as high as 14.8% among examined populations. Understanding the etiology, clinical presentation, and management of this condition is essential for veterinary practice and board examination success.

EcPV Type Prevalence Genus Clinical Notes
EcPV-4 84% (most common) Dyoiotapapillomavirus Primary etiologic agent
EcPV-3 42% Dyorhopapillomavirus Often in coinfection
EcPV-6 18% Dyorhopapillomavirus Regional variation
EcPV-1 34% -- Always with coinfection

Etiology and Pathogenesis

Causative Agent

Aural plaques are caused by infection with Equus caballus papillomavirus (EcPV). Multiple viral types have been identified in association with aural plaques, with EcPV types 3, 4, 5, and 6 being most commonly detected. Recent molecular studies have demonstrated that EcPV-4 is the most prevalent type, found in up to 84% of affected horses, followed by EcPV-3, EcPV-6, and EcPV-1. Coinfection with multiple EcPV types is common, occurring in approximately 59% of cases.

Equus caballus Papillomavirus Types Associated with Aural Plaques

High-YieldEcPV-2 and EcPV-7 are NOT associated with aural plaques. EcPV-2 is associated with penile and preputial squamous cell carcinoma (SCC) in horses. This distinction is important for the NAVLE.

Vector Transmission

Black flies (Simulium spp.) serve as the mechanical vector for EcPV transmission. These hematophagous insects are most active at dawn and dusk, targeting the head, ears, and ventral abdomen of horses. The flies breed in fast-flowing, highly oxygenated water sources such as rivers and streams. The location of aural plaques on the inner pinna correlates with the preferred feeding sites of Simulium species, supporting the vector transmission hypothesis.

Additional factors potentially contributing to transmission include:

  • Direct contact with contaminated fomites (shared tack, grooming equipment)
  • Environmental contamination
  • Culicoides biting midges (less commonly implicated)
Feature Description
Location Concave (inner) surface of the pinna; often bilateral
Appearance Well-demarcated, raised, depigmented (white to gray), hyperkeratotic plaques with a waxy, crusty surface
Size Individual lesions: 1-4 mm; may coalesce to form larger plaques (1-3 cm or more)
Distribution Can be unilateral or bilateral; punctate (less than 5 lesions), multiple (greater than 5 lesions), or coalescing
Secondary Sites Ventral abdomen, sheath, medial thighs, periocular region (less common)

Clinical Presentation

Signalment

Aural plaques can affect horses of any age, breed, or sex, though horses under 1 year of age are rarely affected. No definitive breed predisposition has been established, although some studies suggest Mangalarga Marchador horses may have higher susceptibility compared to Quarter Horses. The condition is more commonly observed in horses managed in semi-intensive systems and those subjected to ear grooming or clipping.

Clinical Signs and Lesion Characteristics

Behavioral Signs

While many horses with aural plaques are asymptomatic, affected horses may exhibit:

  • Ear sensitivity or head shyness
  • Resistance to bridling or haltering
  • Head shaking or tossing
  • Ear-laying or pulling away when ears are touched
  • Aversion to ear clipping or cleaning
NAVLE TipOn the NAVLE, aural plaques are often presented as an incidental finding during routine examination. The key clinical features to recognize are: bilateral, inner pinna, white/depigmented, hyperkeratotic, well-demarcated plaques. Remember that lesions are typically non-painful and non-pruritic unless secondarily infected.
Method Indications Key Findings
Clinical Exam First-line, sufficient in most cases Characteristic lesion morphology and location
Histopathology Atypical cases, rule out neoplasia, research Epidermal hyperplasia, hyperkeratosis, koilocytes, hypergranulosis
PCR Viral typing, research, differentiate from sarcoid Detection of EcPV DNA (types 3, 4, 5, 6)
IHC Confirm PV antigen presence Intranuclear PV antigen in keratinocytes

Diagnosis

Clinical Diagnosis

Diagnosis of aural plaques is typically based on characteristic clinical appearance and does not routinely require laboratory confirmation. The pathognomonic presentation of well-demarcated, depigmented, hyperkeratotic plaques on the inner pinna is usually sufficient for diagnosis.

Diagnostic Methods

Histopathologic Findings

When biopsy is performed, characteristic histopathologic findings include:

  • Mild papillated epidermal hyperplasia (acanthosis)
  • Marked orthokeratotic hyperkeratosis
  • Koilocytosis (cytopathic effect of papillomavirus - enlarged cells with perinuclear clearing and hyperchromatic, irregular nuclei)
  • Hypergranulosis with enlarged, irregular keratohyalin granules
  • Hypomelanosis (decreased pigmentation)
  • Intranuclear viral particles (visible on electron microscopy)

Memory Aid - "KHAKI" for Histopath Findings: K = Koilocytosis, H = Hyperkeratosis, A = Acanthosis (epidermal hyperplasia), K = Keratohyalin granules (enlarged), I = Intranuclear viral particles

Condition Key Distinguishing Features Diagnostic Method
Auricular Sarcoid Hairless, roughened surface; can be nodular or verrucous; may occur at pinna base or edge PCR for BPV-1/BPV-2 DNA; biopsy (CAUTION: may activate growth)
Squamous Cell Carcinoma Ulcerated, invasive mass; older horses; rare progression from chronic aural plaques Histopathology essential
Fly Strike Dermatitis Crusted papules with bloody centers; pruritic; on ear tips Clinical history and distribution
Dermatomycosis Circular, alopecic lesions; scaling; contagious Fungal culture; Wood's lamp
Tick Infestation Visible parasites; localized swelling and irritation Visual identification of ticks

Differential Diagnosis

The most important differential to distinguish from aural plaques is the auricular sarcoid. This distinction is critical as management differs significantly.

High-YieldDistinguishing aural plaques from auricular sarcoids is critical. Aural plaques are caused by EcPV (equine papillomavirus), while sarcoids are caused by BPV (bovine papillomavirus types 1 and 2). PCR from surface swabs can differentiate these conditions without the need for biopsy. This is particularly important because biopsy of sarcoids can stimulate aggressive tumor growth.
Treatment Protocol Efficacy Considerations
Benign Neglect Monitor only; fly protection N/A - management approach First-line for asymptomatic horses
Imiquimod 5% Cream Apply 2-3x weekly (non-consecutive days) every other week for 1.5-8 months 87.5-93% complete resolution; 71% viral clearance Causes marked inflammation; sedation often required; may recur
Topical Steroids After debridement; symptomatic relief Reduces size; does not cure Palliative only
Surgical Removal Debridement; cryosurgery; laser Variable; high recurrence Rarely indicated; may worsen head shyness

Treatment

Treatment of aural plaques is generally not required in asymptomatic horses, as the condition is benign and primarily cosmetic. The decision to treat should be based on whether the plaques cause functional problems (ear sensitivity, bridling difficulties) or significant owner concern.

Treatment Options

Imiquimod Treatment Protocol

Imiquimod 5% cream (Aldara) is an immune response modifier with potent antiviral activity that represents the most effective treatment for aural plaques when intervention is desired.

  • Mechanism: Toll-like receptor 7 agonist; stimulates local cell-mediated immune response
  • Application: Apply thin layer 2-3 times weekly on non-consecutive days, every other week
  • Duration: 1.5-8 months (median 2.9 months)
  • Pre-treatment: Crust removal required; sedation needed in 75% of horses
  • Adverse effects: Marked local inflammation, exudation, thick crust formation; may temporarily worsen head shyness
NAVLE TipFor NAVLE purposes, remember that the treatment of choice when intervention is indicated is imiquimod 5% cream. However, the first-line approach for most horses is benign neglect with fly protection, since the condition is benign and treatment causes significant local inflammation. Lesions typically do NOT spontaneously regress.

Prognosis and Complications

The prognosis for horses with aural plaques is excellent from a health standpoint, as the lesions are benign and do not affect systemic health. Key prognostic considerations include:

  • Chronicity: Lesions are typically non-self-limiting and persist indefinitely without treatment
  • Recurrence: High recurrence rate even after successful treatment due to viral persistence
  • Malignant transformation: Rare; one case report of progression to SCC in a 28-year-old horse with chronic aural plaques and EcPV-4 detection
  • Secondary infection: Plaques are susceptible to fly bites and secondary bacterial infection
  • Economic impact: In some regions, horses with visible aural plaques may be excluded from exhibitions or have reduced commercial value

Prevention

Prevention strategies focus on reducing exposure to the vector (black flies) and minimizing potential fomite transmission:

  • Fly masks with ear covers: Physical barrier to prevent fly access to ears
  • Fly repellents: Apply to ears and head; products such as Deosect (permethrin-based)
  • Stabling at high-risk times: House horses indoors during dawn and dusk when black flies are most active
  • Environmental management: Avoid pastures near fast-flowing water sources; use fans in stables
  • Equipment hygiene: Disinfect shared tack and grooming tools with povidone-iodine
  • Avoid ear clipping: Ear grooming has been associated with increased prevalence of coalescing lesions

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →